![Uwe Schlokat](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Uwe Schlokat
Vorstandsvorsitzender bei Sentinext Therapeutics Sdn. Bhd.
Aktive Positionen von Uwe Schlokat
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Zytoprotec GmbH
![]() Zytoprotec GmbH Pharmaceuticals: MajorHealth Technology Zytoprotec GmbH develops and manufactures drugs for peritoneal dialysis. It specializes in the research and development of its pipeline, which encompasses PD-protec, a patented-protected solution and ICO-protec, a cytoprotective PD solution to address the market for non-glucose based PD solutions. The firm focus areas encompass portfolio management, therapeutic approach, patent management and research services. The company was founded by Karl Altenhuber, Christoph Aufricht and Christian Hoenig in 2007 and is headquartered in Vienna, Austria. | Vorsitzender | - | - |
Direktor/Vorstandsmitglied | - | - | |
PrIME Biologics Pte Ltd.
![]() PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore. | Direktor/Vorstandsmitglied | - | - |
Sentinext Therapeutics Sdn. Bhd.
![]() Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - |
Karriereverlauf von Uwe Schlokat
Ehemalige bekannte Positionen von Uwe Schlokat
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Immuno AG | Corporate Officer/Principal | - | - |
Functional Enviromics Technologies SA
![]() Functional Enviromics Technologies SA BiotechnologyHealth Technology Functional Enviromics Technologies SA provides biotechnology solutions. It develops chemically defined cell culture media for life sciences research institutions and industries. The firm offers cell functional enviromics (CFE) sciences and derived technologies. Its CFE technology engineers cellular metabolism which enables increased cell culture performance and decreases development time for media formulation. The company was founded by Rui Oliveira, Inês Isidro, João Dias, Nuno Carinhas, Filipe Ataíde, and Ana Ferreira in 2013 and is headquartered in Caparica, Portugal. | Direktor/Vorstandsmitglied | - | - |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Ausbildung von Uwe Schlokat
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistik
International
Österreich | 3 |
Deutschland | 2 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 4 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Immuno AG | |
Zytoprotec GmbH
![]() Zytoprotec GmbH Pharmaceuticals: MajorHealth Technology Zytoprotec GmbH develops and manufactures drugs for peritoneal dialysis. It specializes in the research and development of its pipeline, which encompasses PD-protec, a patented-protected solution and ICO-protec, a cytoprotective PD solution to address the market for non-glucose based PD solutions. The firm focus areas encompass portfolio management, therapeutic approach, patent management and research services. The company was founded by Karl Altenhuber, Christoph Aufricht and Christian Hoenig in 2007 and is headquartered in Vienna, Austria. | Health Technology |
Functional Enviromics Technologies SA
![]() Functional Enviromics Technologies SA BiotechnologyHealth Technology Functional Enviromics Technologies SA provides biotechnology solutions. It develops chemically defined cell culture media for life sciences research institutions and industries. The firm offers cell functional enviromics (CFE) sciences and derived technologies. Its CFE technology engineers cellular metabolism which enables increased cell culture performance and decreases development time for media formulation. The company was founded by Rui Oliveira, Inês Isidro, João Dias, Nuno Carinhas, Filipe Ataíde, and Ana Ferreira in 2013 and is headquartered in Caparica, Portugal. | Health Technology |
PrIME Biologics Pte Ltd.
![]() PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore. | Health Technology |
Sentinext Therapeutics Sdn. Bhd.
![]() Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Health Technology |
- Börse
- Insiders
- Uwe Schlokat
- Erfahrung